CELLDEX THERAPEUTICS INC NEW's ticker is CLDXXXXX and the CUSIP is 15117B103. A total of 162 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q4 2013. The put-call ratio across all filers is 0.83 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2016 | $56,000 | -76.8% | 14,928 | 0.0% | 0.00% | – |
Q4 2015 | $241,000 | +53.5% | 14,928 | 0.0% | 0.00% | – |
Q3 2015 | $157,000 | -72.2% | 14,928 | -33.3% | 0.00% | -100.0% |
Q2 2015 | $564,000 | +171.2% | 22,392 | +200.0% | 0.00% | – |
Q1 2015 | $208,000 | -75.4% | 7,464 | -83.9% | 0.00% | -100.0% |
Q4 2014 | $844,000 | +770.1% | 46,423 | +522.0% | 0.00% | – |
Q3 2014 | $97,000 | -65.6% | 7,464 | -65.2% | 0.00% | – |
Q2 2014 | $282,000 | -42.1% | 21,450 | -35.7% | 0.00% | -100.0% |
Q1 2014 | $487,000 | -90.8% | 33,359 | -83.7% | 0.00% | -90.0% |
Q4 2013 | $5,299,000 | -7.6% | 204,238 | +26.2% | 0.01% | 0.0% |
Q3 2013 | $5,736,000 | +60.3% | 161,893 | -29.4% | 0.01% | +42.9% |
Q2 2013 | $3,578,000 | – | 229,182 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
KLP Enterprises, LLC | 6,865,006 | $24,302,000 | 100.00% |
TSP Capital Management Group, LLC | 886,398 | $3,138,000 | 1.60% |
Marcus Capital, LLC | 109,950 | $389,000 | 0.42% |
RTW INVESTMENTS, LP | 239,662 | $848,000 | 0.32% |
COLUMBIA WANGER ASSET MANAGEMENT LLC | 6,195,855 | $21,933,000 | 0.31% |
Benchmark Capital Advisors | 66,800 | $236,000 | 0.20% |
Bellevue Group AG | 160,000 | $566,000 | 0.12% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 632,944 | $2,241,000 | 0.09% |
PDT Partners, LLC | 369,300 | $1,307,000 | 0.09% |
Vident Investment Advisory, LLC | 196,715 | $696,000 | 0.08% |